Teladoc Adds David Schloss as Chief Human Resources Officer
August 21 2017 - 9:40AM
Teladoc, Inc. (NYSE:TDOC), the world’s largest and most trusted
telehealth provider, announced today that David Schloss has joined
the company in the newly created role of chief human resources
officer (CHRO). With extensive experience in global HR management
across the pharmaceutical, biotech and consumer healthcare
industries, Schloss will be instrumental in enabling Teladoc to
support the increasing demands and requirements of the growing
organization.
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/7da51e90-e699-4d61-b5d5-2c8fb31706f8
“As the Teladoc business has evolved and expanded, so too have
our human resource needs, with now more than 1200 employees in
locations around the world. It’s paramount that we build on
our HR foundation to continue to meet the talent acquisition,
employee development and associated compliance needs of a growing
and diverse employee pool,” said Teladoc CEO, Jason Gorevic. “David
not only has the requisite depth of experience and demonstrated
leadership capability, but is also a strong cultural fit to join
the ranks of our executive management team.”
Schloss has spent more than 25 years in the field of HR – the
majority with public companies – and also has the distinction of
being a labor and employment attorney, actively practicing law
early in his career. He most recently held the position of Vice
President of Human Resources at Caladrius Biosciences (formerly
NeoStem), a leading clinical stage cell therapy company with
products targeting autoimmune and cardiology indications. He
was instrumental in helping grow Caladrius’ PCT cell therapy
development and manufacturing business, as well as in the
integration of a corporate acquisition. Prior to that he served in
various executive level management positions in the pharmaceutical
and biotech space, leading HR for a number of companies with
responsibility for performance management, organizational design,
global recruitment, restructuring, HRIS initiatives, and more.
Schloss started his HR career and spent nearly 20 years with
GlaxoSmithKline.
“In today's highly competitive global marketplace, attracting
and retaining the best talent enables industry leaders like Teladoc
to successfully execute on delivering on their mission and best
serving their clients. I look forward to applying my expertise in
building and expanding rapidly growing public companies to support
the future of the Teladoc organization,” said Schloss.
About Teladoc, Inc.Teladoc, Inc. (NYSE:TDOC) is
the largest and most trusted telehealth provider in the world.
Recognized by MIT Technology Review as one of the “50 Smartest
Companies”, Teladoc is forging a new healthcare experience with an
innovative portfolio of virtual care delivery solutions. Currently,
Teladoc serves more than 10,000 clients – from payers to providers
to employers – and more than 20 million members who connect within
minutes to Teladoc’s network of more than 3,100 board-certified,
state-licensed physicians and therapists, 24/7. Teladoc’s services
and solutions marry a highly engaging consumer experience with the
latest in data and analytics, and a highly flexible technology
platform. Teladoc has delivered more than 2.5 million medical
visits for general medical, dermatology, counseling, psychiatry,
sexual health, and tobacco cessation. For additional information,
please visit www.teladoc.com.
Media Contacts:
Courtney McLeod
Director of Public Relations, Teladoc
914-265-6789
cmcleod@teladoc.com
Alexandra Peterson
GCI Health
212-798-9916
alexandra.peterson@gcihealth.com
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Sep 2023 to Sep 2024